Intracerebroventricular Injection of Autologous Adipose-Derived Stem Cells for the Treatment of Alzheimer’s Disease: Experience with the First of Three, 3-patient Cohorts in a “First-in-Human” Phase 1 FDA Trial (P12-3.005)
Year: 2025
Type: article
Study design: Clinical Trial
Source: Neurology
Authors: Christopher Duma, Hans Keirstead, Gabriel Nistor, Jessica Buxton, Sawyer Farmer, Robert Lynn, Karlyssa Chung, Zoe Hareng
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409236993